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Robert H. Fagarda, Katarzyna Stolarzb, Tatiana Kuznetsovaa,c,
Jitka Seidlerovaa,d, Vale´rie Tikhonoffe, Tomasz Grodzickif, Yuri Nikitinc,
Jan Filipovskyd, Jan Peleskag, Edoardo Casigliae, Lutgarde Thijsa,
Jan A. Staessena and Kalina Kawecka-JaszczbObjective To assess, in a population-based approach,
sympathetic nervous system activity by the use of power
spectral analysis of heart rate variability, in normotension,
white-coat hypertension, masked hypertension and
sustained hypertension.
Methods The electrocardiographic RR interval was
registered in the supine and standing positions and the low-
frequency and high-frequency components of its variability
were quantified. Cut-off values of 140/90 mmHg for
conventional blood pressure and 135/85 mmHg for daytime
ambulatory blood pressure were used to define the four
blood pressure groups.
Results After exclusion of patients with diabetes, myocardial
infarction or treated hypertension, 1485 subjects with
complete data remained for the analysis in the supine
position. Age averaged 39 W 14 years; 54% were women.
Conventional and ambulatory blood pressure averaged,
respectively, 122 W 16/79 W 11 mmHg and 124 W 12/
77 W 8 mmHg. After adjusting for demographic,
anthropometric and lifestyle characteristics, the low-
frequencytohigh-frequencyratio(geometricmean)averaged
0.81 in normotension and was significantly higher in
white-coat hypertension (1.11; P < 0.001), based on a higher
low-frequency component and a lower high-frequency
component (P < 0.01). This ratio was not significantly different
between normotension, masked hypertension (0.97) and
sustained hypertension (0.93). The adjusted standing-to-
supine ratio of the high-frequency component (geometricopyright © Lippincott Williams & Wilkins. Unautho
0263-6352  2007 Wolters Kluwer Health | Lippincott Williams & Wilkinsmean) was significantly higher in sustained hypertension
(0.50) than in normotension (0.39; P < 0.01), but not in
white-coat (0.40) and masked hypertension (0.45).
Conclusion The findings at rest are compatible with
increased sympathetic activity and decreased
parasympathetic modulation in white-coat hypertension,
with normal autonomic cardiac regulation in masked
and sustained hypertension. In addition, sustained
hypertension is characterized by a blunted decrease
of the high-frequency component on standing.
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Measurements of plasma catecholamines and norepi-
nephrine spill-over, data from direct recordings from
peripheral nerves and from power spectral analysis
(PSA) of heart rate variability (HRV), and responses to
pharmacological blockade suggest that the autonomic
nervous system contributes to the development and
maintenance of high blood pressure in human essential
hypertension, or at least in subsets of patients. These
investigations pointed to stimulation of the sympathetic
nervous system (SNS) or a decrease in parasympathetic
activity [1–5]. Data on the activity of the SNS have not,
however, always been consistent [6]. In addition, thedefinition of normotension and hypertension has usually
been based on clinic blood pressure measurements in
these studies, without considering out-of-office blood
pressure. When both clinic and out-of-office blood pres-
sure measurements are taken into account, four blood
pressure categories can be identified: true normotension,
white-coat hypertension (WCHT), masked hypertension
(MHT) and sustained hypertension (SHT). Therefore,
hypertensive and normotensive controls may, respect-
ively, have included patients with WCHT or MHT.
Several more recent studies have reported on WCHT
separately, and found that SNS activity is deranged
in WCHT [7–10], or that the white-coat effect isrized reproduction of this article is prohibited.
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however, available on MHT. Furthermore, it has been
suggested that sympathetic tone tends to decrease in later
phases of hypertension [4,6,9]. Another possible concern
is that most studies on the role of the SNS have been
performed on selected hypertensive patients and controls,
which may have influenced the results. The purpose of this
population-based study was to assess heart rate and the
spectral components of its variability as indices of SNS
activity in the different types of hypertension. PSA of
short-term beat-to-beat HRV, which is largely dependent
on the functioning of the autonomic nervous system,
provides a non-invasive method to assess autonomic car-
diac modulation, suitable for studies in the population.
Methods
Study population
The study population was recruited in eight centres in
Europe, that is one centre in Belgium, Bulgaria, Italy,
Poland, Romania and the Russian Federation, and two
centres in the Czech Republic. The study was part of the
EPOGH project (European Project on Genes in Hyper-
tension) and was coordinated by the Hypertension Unit
of the University of Leuven K.U. Leuven. The sampling
unit consisted of randomly recruited households in a
Flemish rural area in Belgium [5,12] and of nuclear
families in the other centres [13]. The study was
approved by the ethics committee of each centre and
the subjects gave informed consent.
Study protocol
Investigations were performed throughout the day in
local examination centres, as described, mostly on week
days [5,12,13]. Subjects refrained from smoking, heavy
exercise, and drinking alcohol or caffeine-containing
beverages for at least 2 h before the examinations. They
completed a questionnaire on medical history, smoking
habits, consumption of alcohol, occupational and leisure-
time physical activity, and use of medication. After
measurements of height and weight, conventional blood
pressure was taken five times by use of the auscultatory
technique (Korotkoff phases 1 and 5) by trained inves-
tigators, after 5 min of rest in the sitting position; the five
measurements were averaged for the analyses. A suitable
lead was then selected from the 12-lead electrocardio-
gram (ECG) for the study of HRV. After the subjects had
rested for 20 min in the supine position, the ECG signal
was recorded during 15 min in the supine position and
15 min in the free-standing position, together with
the signal from a nasal thermistor to assess respiratory
frequency.
The analysis of heart rate, HRV and the analysis of
respiratory activity has previously been described in
detail [12,13]. Analyses were performed in segments of
512 consecutive beats unless only shorter periods were
suitable for analysis. The mean RR interval (ms) and itsopyright © Lippincott Williams & Wilkins. Unauthtotal power (ms2) and partial power (power between 0.03
and 0.50 Hz; ms2) were calculated. PSA was then per-
formed by fast Fourier transform to estimate the powers
in the low-frequency and high-frequency ranges. The low
and high-frequency components included the power
from 0.05 to 0.15 Hz and from 0.15 to 0.50 Hz, respect-
ively [14], and were expressed in normalized units
(absolute units divided by partial power; %). In addition,
the low-frequency : high-frequency power content ratio
was calculated. We have previously shown that there
were no significant differences between measurements
in the morning and in late afternoon [15].
Ambulatory blood pressure (ABP) monitoring was
performed with validated devices. The recorders were
programmed to obtain measurements at an interval of
15–20 min from 0800 until 2200 h and every 30–
45 min for the remainder of the time. Results are from
unedited recordings. We calculated the average daytime
ABP from 1000 to 2000 h [16] and the average 24-h
ABP, weighted by the time interval between successive
readings. In the primary analysis, subjects with normal
conventional blood pressure (< 140/90 mmHg) and nor-
mal daytime ABP (< 135/85 mmHg) were classified as
true normotensives. White-coat hypertensives had iso-
lated conventional blood pressure elevation, masked
hypertensives isolated ambulatory hypertension, and
both blood pressures were elevated in subjects with
SHT. In a secondary analysis, we used the average
24-h ABP for the classification of the subjects in the four
categories, with cut-off values of 130 mmHg for systolic
blood pressure and 80 mmHg for diastolic blood pressure.
Statistical analysis
Database management and statistical analyses were per-
formed using SAS software version 8.2 (SAS Institute
Inc., Cary, North Carolina, USA). Values are reported as
means and standard deviation (SD) or as proportions.
Variables with positively skewed distribution were nor-
malized by logarithmic transformation and are reported as
geometric means (antilog of mean log). Statistical
analyses were performed by the use of the Student’s
t-test, analysis of variance, analysis of covariance and
regression analysis. We adjusted for age, sex, body mass
index (BMI), smoking (coded 1 for current smokers and
0 for non-smokers), alcohol consumption (coded 1 for
drinkers and 0 for teetotalers), physical activity during
leisure time (sports and walking) and at work, expressed
in energy expenditure (kcal), and centre (seven design
variables). Adjustment for multigroup comparisons was
performed by Scheffe´’s test. We also assessed whether
there were significant interactions between blood pres-
sure group and centre, and performed sensitivity analyses
with the consecutive exclusion of each centre from the
analyses. Orthostatic changes are expressed as standing-
to-supine ratios. A two-tailed P value of 0.05 or less was
considered significant.orized reproduction of this article is prohibited.
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Table 1 Characteristics of the study population by blood pressure group
Normotension WCHT MHT SHT Overall P value
Number 1020 146 176 143
Age (years) 36.113.5 49.513.8a 39.914.1a,b 47.712.0a,c <0.001
Sex (% women) 61.5 43.2a 36.4a 32.9a <0.001
Body mass index (kg/m2) 23.94.2 27.14.6a 25.43.8a,b 27.54.3a,c <0.001
Smokers (%) 29.1 17.8a 38.1b 33.6b <0.001
Alcohol users (%) 27.6 29.5 45.5a,b 51.7a,b <0.001
Energy expenditure (kcal/day) 1664930 16741288 1810956 1542919 0.11
Blood pressure (mmHg)
Clinic
Systolic 115.610.7 141.814.9a 123.49.2a,b 148.815.6a,b,c <0.001
Diastolic 74.97.9 92.26.1a 79.37.3a,b 95.610.3a,b,c <0.001
Daytime
Systolic 119.28.0 124.87.0a 136.37.3a,b 142.711.5a,b,c <0.001
Diastolic 73.85.4 77.85.3a 85.66.2a,b 90.37.8a,b,c <0.001
MHT, Masked hypertension; SHT, sustained hypertension; WCHT, white-coat hypertension. Values are meansSD or proportions. Significant differences between groups
according to Scheffe´’s test (P0.05): comparison with, respectively, anormotension, bWCHT and cMHT.
Table 2 Determinants of the difference between conventional
blood pressure and daytime ambulatory pressure: results from
multivariable regression analysis
CBPDaytime ABP
Systolic Diastolic
Blood pressure (mmHg)a þ0.345z þ0.244z
Age (years) þ0.275z þ0.073z
Sex (women, 1; men, 0) þ1.74y 2.04z
Body mass index (kg/m2) NS þ0.322z
Smoking (yes, 1; no, 0) 2.04y 1.37y
Use of alcohol (yes, 1; no, 0) 1.51M 1.20M
Energy expenditure (kcal/day) NS NS
Intercept 56.4z þ24.1z
R2 0.25 0.16
ABP, Ambulatory blood pressure; CBP, conventional blood pressure. Data are
regression coefficients. The regression models for the difference between daytime
ambulatory blood pressure and conventional blood pressure as the dependent
variable are obtained by changing the sign of the regression coefficients. a Blood
pressure is the average of conventional blood pressure and daytime ambulatory
blood pressure. MP0.05; yP0.01; zP0.001.Results
A total of 2490 subjects were investigated in the local
examination centres. The response rate of invited subjects
in the various centres ranged from 54 to 82% (weighted
mean 64%). For the current analyses we excluded partici-
pants with at least one of the following conditions: age less
than 18 years (n¼ 25); diabetes (n¼ 96); history of myo-
cardial infarction (n¼ 16); antihypertensive treatment
(n¼ 415); missing demographic or anthropometric data
(n¼ 108); missing or inadequate data with regard to con-
ventional blood pressure (n¼ 97) or ABP measurements
(n¼ 263), or with regard to recordings for the analysis of
HRV in the supine position (n¼ 322). A total of 1485 of the
2490 subjects had none of these conditions and remained
for the analyses. Their age averaged 39.0 14.3 years and
BMI averaged 24.8 4.4 kg/m2; 53.9% were women,
29.5% smoked and 32.2% used alcohol. Conventional
blood pressure averaged 122.3 16.4/79.1 10.9 mmHg
and daytime ABP averaged 124.0 11.6/77.2 8.1 mmHg.
mmHg. The contribution of the different countries was as
follows: Belgium, 30.1%; Russian Federation, 15.5%;
Poland, 15.3%; Czech Republic, 13.3%; Italy, 12.7%;
Romania, 8.3%; and Bulgaria, 4.8%. A total of 1379 of
the 1485 subjects had adequate recordings for the analysis
of HRV in the standing position.
Table 1 summarizes the major characteristics of the
subjects according to blood pressure group. Of the
1485 subjects, 68.7% were normotensive and, respect-
ively, 9.8, 11.9 and 9.6% had WCHT, MHT and SHT.
The groups differed significantly with regard to age, sex,
BMI, and lifestyle characteristics, but not for energy
expenditure (Table 1).
The difference between conventional blood pressure and
daytime ABP averaged 1.7 13.7 mmHg for systolic
blood pressure and þ1.9 9.4 mmHg for diastolic blood
pressure in the total study population. Table 2 gives
the results from multivariable regression analysis on the
determinants of the white-coat effect; blood pressure was
included in this analysis as the average of conventionalopyright © Lippincott Williams & Wilkins. Unauthoblood pressure and daytime ABP. The difference between
conventional blood pressure and daytime ABP became
larger with increasing blood pressure and age, and was
smaller in smokers and drinkers, with no effect of energy
expenditure. The reverse holds for the difference between
daytime ABP and conventional blood pressure.
Table 3 summarizes the overall results on heart rate,
HRV and breathing frequency in the supine and standing
positions. Heart rate, the low-frequency component of its
variability, the low-frequency : high-frequency ratio and
breathing frequency were higher in the standing than in
the supine position, whereas total and partial power
and the high-frequency component were lower. The
standing-to-supine ratio averaged 1.27 for heart rate,
1.53 and 0.41 for the low and high-frequency com-
ponents, respectively, and 3.71 for the low-frequency :
high-frequency ratio (geometric mean for the latter three
variables; P< 0.001 for all).
Table 4 summarizes the relationships of conventional
blood pressure and daytime ABP, and of their difference,
with heart rate and the components of its variability.rized reproduction of this article is prohibited.
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Table 3 Heart rate and heart rate variability in the supine and
standing position
Supine Standing
Number 1485 1379
RR-interval (ms) 923135 736111
Heart rate (min1) 66.49.7 83.412.5
Total power (log ms2)
(geometric mean)
3.270.43 (1851) 3.070.41 (1182)
Partial power (log ms2)
(geometric mean)
3.060.49 (1143) 2.820.45 (666)
LF component (%) 39.615.6 58.316.9
HF component (%) 46.019.0 21.414.4
LF : HF ratio (log)
(geometric mean)
0.0610.393 (0.87) 0.5080.416 (3.22)
Breathing frequency (min1) 15.83.2 16.13.4
HF, High-frequency; LF, low-frequency. Values are meansSD. P<0.001 for chan-
ges from supine to standing position in the 1379 subjects with data in both positions.Systolic and diastolic conventional blood pressure and
daytime ABP were positively and independently related
to heart rate and the low-frequency : high-frequency ratio
and negatively to the high-frequency component; in
addition, diastolic blood pressure was positively related
to the low-frequency component. It is of note that the
relationships were similar for conventional blood pressure
and daytime ABP, and that the difference between
conventional blood pressure and daytime ABP was not
related to the HRV components.
Table 5 summarizes the results on HRV in the four
groups of subjects in the supine position, with adjustment
for centre and demographic, anthropometric and lifestyle
characteristics. Subjects with WCHT had a higher low-
frequency component (P< 0.01) and low-frequency :
high-frequency ratio (P< 0.001) and a lower high-
frequency component (P< 0.001) than normotensive
individuals. The components of HRV were not signifi-
cantly different between MHT, SHT and normotension.
Heart rate was slightly higher in SHT than in normoten-
sion (P< 0.05). Among the demographic, anthropometric
and lifestyle characteristics, age, sex and smoking were
significantly and independently related to the com-
ponents of HRV (P< 0.001 for all). For example, the
low-frequency : high-frequency ratio increased with
aging, was lower in women than in men, and was lower
in smokers than in non-smokers. The analyses on the
inter-group comparisons of the components of HRV andopyright © Lippincott Williams & Wilkins. Unauth
Table 4 Relationships of conventional blood pressure and daytime amb
components of heart rate variability
CBP
Systolic blood pressure (mmHg)
Heart rate (min1) þ0.1960.03795z
LF (%) þ0.04060.0236
HF (%) 0.05440.0203y
LF : HF (log) þ2.2470.958M
Diastolic blood pressure (mmHg)
Heart rate (min1) þ0.1300.0253z
LF (%) þ0.05660.0157z
HF (%) 0.05530.0135z
LF : HF (log) þ2.5550.638z
HF, High-frequency; LF, low-frequency. Data are regression coefficientsSE, with adju
centre. MP0.05; yP0.01; zP0.001.the low-frequency : high-frequency ratio were repeated
with the consecutive exclusion of each centre. In each of
these analyses the results were similar to the overall
results. In addition, the interaction term between blood
pressure group and centre was never significant. Finally,
results on the inter-group comparisons of HRV were
similar when the average 24-h ABP rather than daytime
ABP was used for the classification of the subjects in
the four blood pressure categories.
Table 6 gives the adjusted results for the standing-to-
supine ratio for the four groups of subjects. The response
to standing was not significantly different between
WCHT, MHT and normotension. SHT showed a lesser
decrease in the high-frequency component on standing
(P< 0.01) with a smaller increase in the low-frequency :
high-frequency ratio (P¼ 0.07). The standing-to-supine
ratio of heart rate tended to be lower in SHT (1.24) than
in normotension (1.27; P¼ 0.08).
Discussion
Normotension and hypertension have classically been
defined on the basis of a normal or elevated conventional
blood pressure, but it has been recognized that out-of-
office blood pressure may be elevated in subjects with
normal conventional blood pressure (MHT), or may be
normal in subjects with high conventional blood pressure
(WCHT). In the current population-based study,
WCHT, MHT and SHT were present in, respectively,
68.7, 9.8, 11.9 and 9.6% of the participants. It is, however,
likely that the prevalence of WCHT and SHT was
underestimated because we excluded subjects treated
with antihypertensive drugs, and subjects with high
conventional blood pressure are more likely to be treated
than others. The true prevalence of the different forms of
hypertension is not known in our study population
because conventional blood pressure and ABP before
the initiation of antihypertensive treatment are not avail-
able. Nevertheless, the data shed some light on the gen-
eral characteristics of the different types of hypertension.
There were more men than women in the three hyper-
tension groups than in normotension. Age and BMI were
higher in hypertensive individuals, the differences with
normotension being smallest for MHT. The prevalenceorized reproduction of this article is prohibited.
ulatory blood pressure and their difference, with heart rate and the
Daytime ABP CBPABP
þ0.06990.0290M þ0.1260.0334z
þ0.02800.0179 þ0.01250.0207
0.03860.0154y 0.01580.0178
þ1.7340.728M þ0.5120.841
þ0.0850.0213z þ0.0430.0241
þ0.06090.0131z 0.004310.0149
0.05350.0113z 0.001710.0128
þ2.6990.532z 0.1440.606
stment for age, sex, body mass index, energy expenditure, smoking, alcohol use and
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Table 5 Heart rate and heart rate variability in the supine position by blood pressure group
Normotension WCHT MHT SHT Overall P value
Number 1020 146 176 143
Heart rate (min1) 65.99.5 67.49.7 66.79.4 68.79.7M <0.01
Total power (log ms2) (geometric mean) 3.270.38 (1874) 3.280.39 (1886) 3.300.38 (1985) 3.180.39§ (1526) <0.05
Partial power (log ms2) (geometric mean) 3.070.41 (1164) 3.050.42 (1120) 3.080.41 (1212) 2.980.42 (955) 0.11
LF component (%) 38.815.4 43.715.7y 41.315.2 39.615.6 <0.01
HF component (%) 47.417.9 40.918.2z 44.317.7 43.918.2 <0.001
LF : HF ratio (log) (geometric mean) 0.0890.378 (0.81) 0.0470.385z (1.11) 0.0120.374 (0.97) 0.0300.384 (0.93) <0.001
HF, High-frequency; LF, low-frequency; MHT, Masked hypertension; SHT, sustained hypertension; WCHT, white-coat hypertension. Values are adjusted meansSD and
geometric means. Values are adjusted for age, sex, body mass index, energy expenditure, smoking, alcohol use and centre. Scheffe´’s intergroup comparisons according to
Scheffe´’s test: MP0.05; yP0.01; zP0.001 versus normotension; §P¼0.09 versus normotension and P¼0.06 versus MHT; all other comparisons: P>0.10.of smoking and drinking was highest in MHT and SHT,
which may have influenced ABP.
The main purpose of the present study was to assess the
activity of the SNS in the three types of hypertension
in comparison with true normotension by use of the
measurement of HRV in special examination centres.
After adjusting for demographic, anthropometric and life-
style characteristics, several of which differed significantly
among the groups, we found evidence of a derangement of
the SNS in WCHT, which is a higher low-frequency : high-
frequency ratio, resulting from a higher low-frequency
component and a lower high-frequency component in
comparison with normotension, compatible with increased
sympathetic activity and decreased parasympathetic
modulation [10]. Involvement of the SNS in WCHT
has also been shown by other measurements in the clinic
setting, such as microneurography [8,9] and an assess-
ment of plasma norepinephrine [7]. The observation by
Pierdomenico et al. [17] that the low-frequency : high-
frequency ratio is higher in WCHT than in normotension
in the period around the clinic visit but not during the rest
of the time during 24-h ECG monitoring suggests that the
increased low-frequency : high-frequency ratio in WCHT
could be the result of an alerting reaction in the clinical
setting. The fact that the white-coat effect, used as a
continuous variable, was not significantly related to the
components of HRV, suggests a more fundamental invol-
vement of the SNS in WCHT.
We are not aware of data on the activity of the SNS in
MHT. Heart rate and the components of its variability
were no different between MHT and normotension,
suggesting that the SNS is not involved in this type ofopyright © Lippincott Williams & Wilkins. Unautho
Table 6 Standing-to-supine ratio for heart rate and heart rate variabili
Normotension WCHT
Number 945 140
Heart rate 1.270.14 1.260.14
Total power 0.9470.109 0.9470.111
Partial power 0.9310.127 0.9380.130
LF component (log) (geometric mean) 0.1920.221 (1.56) 0.1640.225
HF component (log) (geometric mean) 0.4040.294 (0.39) 0.3740.300
LF : HF ratio (log) (geometric mean) 0.5960.445 (3.95) 0.5380.454
HF, High-frequency; LF, low-frequency; MHT, Masked hypertension; SHT, sustained hy
geometric means. Values are adjusted for age, sex, body mass index, energy expenditure
Scheffe´’s test: yP0.01 versus normotension; MP¼0.08 versus normotension; zP¼hypertension, at least not when assessed by the use of
HRV. It is possible that the elevated ABP is to some
extent related to lifestyle factors, as indicated by the
higher prevalence of smoking and use of alcohol than in
normotension, which is confirmed in the continuous
analysis of the determinants of the difference between
daytime ABP and conventional blood pressure.
At variance with the results of Neumann et al. [10] in
selected hypertensive patients, the adjusted values of the
low-frequency : high-frequency ratio and of its two com-
ponents were no different between SHT and normoten-
sion. There are three possible explanations for this finding.
First, they are consistent with the theory that sympathetic
hyperactivity may be involved in the development of
essential hypertension, and that in turn this may then
modulate sympathetic hyperactivity and induce functional
downregulation after prolonged sympathetic stimulation
[4,6,9]. For example, Greenwood et al. [6] observed by the
use of single-unit microneurography that high-normal
blood pressure and mild (stage 1) hypertension were
characterized by a state of increased central sympathetic
drive in comparison with normotensive subjects, but that
the greater sympathetic activity was less pronounced in
more severe hypertension. Second, because there are
separate nerves controlling the heart and blood vessels,
the degree of sympathetic stimulation may differ in the
heart and in the peripheral vasculature [18]. Functional
downregulationofcardiac responsesmaybeparalleledwith
functional upregulation of vascular responses [19]. This is
compatible with the observation by the use of microneur-
ographythatmusclesympatheticnerveactivity is ingeneral
higher in patients with essential hypertension than in
normotensive individuals [6,20], and that the elevatedrized reproduction of this article is prohibited.
ty by blood pressure group
MHT SHT Overall P value
164 130
1.260.14 1.240.14M 0.06
0.9360.108 0.9600.111 0.32
0.9230.126 0.9430.129 0.55
(1.46) 0.1660.218 (1.46) 0.1770.224 (1.50) 0.33
(0.42) 0.3450.291 (0.45) 0.3050.298y (0.50) <0.01
(3.45) 0.5110.440 (3.24) 0.4820.451z (3.03) 0.01
pertension; WCHT, white-coat hypertension. Values are adjusted meansSD and
, smoking, alcohol use, and centre. Scheffe´’s intergroup comparisons according to
0.07 versus normotension; all other comparisons: P0.10.
CHeart rate variability in hypertension Fagard et al. 2285cardiac norepinephrine spillover in hypertensive patients
can be explained, at least partly, by impaired cardiac
neuronal norepinephrine reuptake [21]. Third, PSA of
HRV does not directly assess central sympathetic dis-
charge, but the response of the cardiac sinus node, so that
reduced responsiveness to beta-adrenergic stimulation
may also be involved [4].
We also addressed the response of heart rate and HRV to
standing and observed impaired reduction of the high-
frequency component and a blunted increase of the low-
frequency : high-frequency ratio in SHT. This is compa-
tible with another study that indicated a clear impairment
of standing-induced changes in spectral autonomic indices
in hypertension and even prehypertension [18]. The
response to standing was not significantly different
between normotension, WCHT and MHT, although a
trend towards a progressive impairment was observed.
A number of potential limitations have to be considered.
Conventional blood pressure was measured at one visit to
the examination centre, and measurements of ABP and
HRV have only been performed once, which may have
affected the results. As discussed, PSA of HRV assesses
only one aspect of SNS activity, that is the response of the
cardiac sinus node to the sympathetic and vagal dis-
charge. Data were collected in eight centres throughout
Europe, but we found no evidence that the results would
differ among the centres.
In conclusion, the findings at rest are compatible with
increased sympathetic activity and decreased parasym-
pathetic modulation in WCHT, with normal autonomic
cardiac regulation in MHT and SHT. In addition, SHT is
characterized by a blunted decrease of the high-fre-
quency component on standing.
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